Foundayo vs Wegovy: Daily Pill vs Weekly GLP-1 Shot
Medically reviewed by Medical Advisory Board Last reviewed 2026-08-10
Same GLP-1 mechanism, two very different delivery methods — orforglipron's pill against semaglutide's weekly injection
Foundayo (orforglipron) and Wegovy (semaglutide) both work through the same GLP-1-receptor mechanism and are both FDA-approved for chronic weight management, but Foundayo is a once-daily pill and Wegovy is a once-weekly injection. This guide compares their trial results, dosing burden, and who each one suits.
This article is for informational purposes only and is not medical advice. Consult a physician before starting or switching a weight-loss medication.
Foundayo (orforglipron) and Wegovy (semaglutide) both activate the same GLP-1 receptor, so their weight-loss mechanism is closely related — unlike the Foundayo-vs-Zepbound comparison, where Zepbound's added GIP-receptor activity is the main source of the difference. Here, the real distinction is delivery: Foundayo is a once-daily, room-temperature pill with no food or water restriction, while Wegovy is a once-weekly refrigerated injection.
Want expert help with your metabolic health?
We can match you with a metabolic-medicine specialist who understands this area — so you get the right doctor, not just any doctor.
Book An Appointment With A Specialist →For how Foundayo compares against the strongest weekly option, see Foundayo vs Zepbound. For the full landscape of oral GLP-1s, see our oral GLP-1 pills comparison.
Foundayo vs Wegovy: Side-by-Side
| Factor | Foundayo (orforglipron) | Wegovy (semaglutide) |
|---|---|---|
| Mechanism | GLP-1 receptor agonist (non-peptide small molecule) | GLP-1 receptor agonist (peptide) |
| Delivery | Once-daily oral pill — any time of day, no food/water restriction | Once-weekly subcutaneous injection |
| FDA approval (weight management) | 2026 | June 2021 |
| Average weight loss (pivotal trial) | ~12.4% at the highest studied dose | ~14.9% (STEP-1, 68 weeks) |
| Needles required | None | Yes — weekly self-injection |
| Storage | Room-temperature pill | Refrigerated pen |
| Track record | Newly approved — limited real-world data | 4+ years of real-world prescribing data |
Why the Weight-Loss Numbers Are So Close
Foundayo and Wegovy share the same core mechanism — both activate the GLP-1 receptor — so their pivotal trial results land in a similar range: roughly 12.4% average weight loss for Foundayo versus roughly 14.9% for Wegovy. That's a much smaller gap than the Foundayo-vs-Zepbound comparison, where Zepbound's added GIP-receptor activity pushes results meaningfully higher.
The small remaining gap likely comes down to differences in receptor binding, dose titration schedule, and trial population rather than a fundamentally different mechanism — this is much closer to a delivery-method decision than an efficacy decision.
The Pill-vs-Shot Decision
Foundayo's daily pill avoids needles, refrigeration, and cold-chain travel logistics entirely — a real advantage for anyone with needle aversion or a travel-heavy schedule. The trade-off is a daily habit instead of a weekly one, and daily adherence is generally harder to sustain over months than a once-a-week routine.
Wegovy's weekly injection means only 52 dosing events a year and a much longer real-world track record — over four years of prescribing data compared to Foundayo's brand-new approval. For most people already comfortable with self-injection, Wegovy's established evidence base is still the lower-risk choice today.
Access and Cost
Wegovy has an established manufacturer savings program and over four years of insurance-formulary precedent. Foundayo is brand-new, so insurance coverage decisions and manufacturer discount programs are still settling — expect more formulary friction in Foundayo's first year on the market.
Both require a prescription and medical supervision, and coverage varies significantly by plan for either drug.
The Verdict
The two are close on results — the real decision is pill versus shot. If avoiding needles and refrigerated storage matters most, and you're comfortable being an early adopter of a newly approved drug, Foundayo is a real, FDA-approved option. If you want the longer track record and slightly higher average trial results, Wegovy remains the better-established choice today. Take our free assessment or book a consultation to talk through which fits your history.
What to Look For in a Body-Composition Scale
A bioimpedance scale trends body fat and muscle rather than just weight — useful when the number stalls but your composition is improving. The absolute body-fat % isn't lab-accurate, so use it for TRENDS at a consistent time of day. Choose one that syncs to an app so you can watch the trend line.
Frequently Asked Questions
Is Foundayo as strong as Wegovy for weight loss?
Very close — Foundayo (orforglipron) produced roughly 12.4% average weight loss in its pivotal trial at the highest studied dose, compared to roughly 14.9% for Wegovy (semaglutide). Both activate the same GLP-1 receptor, which is why the results are closer than Foundayo's comparison against the dual-mechanism Zepbound.
Is Foundayo the same drug as orforglipron?
Yes. Foundayo is the FDA-approved brand name for orforglipron, Eli Lilly's once-daily oral GLP-1 receptor agonist.
Can I switch from Wegovy to Foundayo?
Switching between GLP-1 drugs is possible with medical guidance, though it isn't a like-for-like swap — the two have different dosing schedules and titration protocols. A prescriber typically restarts titration on the new drug rather than converting an equivalent dose directly.
Which has fewer side effects, Foundayo or Wegovy?
Both cause similar gastrointestinal side effects during dose escalation — nausea, diarrhea, and constipation are common to both. Because Foundayo is newly approved, its full real-world side-effect profile is still being established, while Wegovy has over four years of broader post-marketing safety data.
Is Foundayo cheaper than Wegovy?
There's no consistent answer yet — Foundayo is new to the market, so insurance coverage and manufacturer savings programs are still settling. Wegovy has an established savings card and more predictable formulary coverage after years on the market. Check your specific insurance plan and each manufacturer's current savings program before assuming either is cheaper for you.
Topic updates
Get the weekly metabolic health roundup
Insulin resistance, blood sugar, visceral fat, GLP-1 plateaus, metabolic syndrome, and weight-loss physiology.
Check Where You Stand
Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Related Comparisons
-
Ozempic vs Wegovy: Same Drug (Semaglutide), Different Use and Dose
Ozempic vs Wegovy: both are semaglutide — the real differences in approval, dose, and coverage.
-
Saxenda vs Wegovy: Daily Liraglutide vs Weekly Semaglutide Weight-loss Injection Compared
Saxenda vs Wegovy: daily liraglutide vs weekly semaglutide — trial results, convenience, and track record.
-
Foundayo vs Zepbound: New Oral GLP-1 Pill vs the Strongest Weekly Injection Compared
Foundayo vs Zepbound: new daily GLP-1 pill vs the strongest weekly dual-mechanism injection.
See more related comparisons
-
Foundayo vs Ozempic: Obesity-approved Pill vs Diabetes-branded Weekly Shot Compared
Foundayo vs Ozempic: obesity-approved daily pill vs diabetes-branded weekly shot — approval pathway explained.
-
Foundayo vs Mounjaro: Obesity-approved Pill vs Diabetes-branded Dual-action Drug Compared
Foundayo vs Mounjaro: obesity-approved daily pill vs diabetes-branded dual-action drug — approval pathway explained.
-
Wegovy vs Zepbound: Same Mechanism, Different Numbers — Which FDA-approved Weight-loss Injection Wins?
Wegovy vs Zepbound: FDA-approved weight-loss injections compared on results, CV data, and cost.
-
Wegovy vs Mounjaro: On-label Weight-loss Approval vs Off-label Diabetes Drug Compared
Wegovy vs Mounjaro: on-label weight-loss approval vs off-label diabetes drug compared.
-
Wegovy Alternatives: 6 Options Compared for Weight Management
Wegovy alternatives ranked: Zepbound, off-label Ozempic, compounded semaglutide, metformin, lifestyle.
Affiliate disclosure: The Metabolic Journal is reader-supported. Some links above are affiliate or referral links and we may earn a commission at no extra cost to you. As an Amazon Associate we earn from qualifying purchases. Products are chosen on the merits; commissions never influence what we recommend. This is general information, not medical advice — talk to your clinician before acting.